CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs.

The pharmaceutical formulation of a new anti-tumour agent has often been perceived as the bottleneck in anti-cancer drug development. In order to increase the speed of this essential development step, the Cancer Research Campaign (CRC), the European Organization for Research and Treatment of Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Beijnen, J. H., Flora, K. P., Halbert, G. W., Henrar, R. E., Slack, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034157/
https://www.ncbi.nlm.nih.gov/pubmed/7599054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034157/
https://www.ncbi.nlm.nih.gov/pubmed/7599054

Ejemplares similares